Messenger RNA (mRNA), is a single-stranded molecule in cells that carries codes from the DNA in the nucleus to the sites of protein synthesis in the cytoplasm (the ribosomes). With the major technological innovation and research investment, mRNA has become a promising therapeutic tool in in a variety of applications, including cancer immunotherapy, infectious disease vaccines, protein substitution and cellular genetic engineering. mRNA-based therapeutics hold the potential to cause a major revolution in the pharmaceutical industry because they can be used for precise and individualized therapy, and enable patients to produce therapeutic proteins in their own bodies without struggling with the comprehensive manufacturing issues associated with recombinant proteins. Compared with the current therapeutics, the production of mRNA is much cost-effective, faster and more flexible because it can be easily produced by in vitro transcription, and the process is independent of mRNA sequence. In addition, with the ease of rapid, large scale Good Manufacturing Practice-grade (GMP-grade) mRNA production, mRNA is ideally poised potential drug candidate that will meet the needs of gene therapy, cancer therapy as well as vaccination and so on.

As one of the global leading biotechnology companies, Creative Biogene is able to offer the dedicated service for the synthesis of GMP-grade mRNAs to customers worldwide. With our unparalleled expertise and experience in mRNA synthesis and the comprehensive QC and QA program, Creative Biogene is available to produce any mRNAs ranging from a few hundred nucleotides to kilobases in length as cost effectively and quickly as possible without compromising on quality. If you have any special requirements in GMP-grade mRNA services, please feel free to contact us. We are looking forward to working together with your attractive projects.

• Hanna Cole
•